Galectin Therapeutics Inc. Share Price
NASDAQ: GALT | Micro CapGalectin Therapeutics Inc. Stock Performance
Open $3.38 | Prev. Close $3.22 | Circuit Range N/A |
Day Range $3.25 - $3.49 | Year Range $2.02 - $7.13 | Volume 15,209 |
Average Traded $3.38 |
Galectin Therapeutics Inc. Share Price Today
As of 10 August 2026, Galectin Therapeutics Inc.'s share price is $3.45. The stock opened at $3.38, compared to its previous close of $3.22. During today's trading session, Galectin Therapeutics Inc.'s share price traded between $3.25 and $3.49, with an average price of $3.37. Over the past 52 weeks, the stock has recorded a high of $7.13 and a low of $2.02. In terms of performance, Galectin Therapeutics Inc.'s share price has risen by 15.97% over the last six months and is down 18.82% on a year-on-year basis.
Galectin Therapeutics Inc. Share Price Chart
Galectin Therapeutics Inc. Stock Fundamentals & Key Indicators
Market Cap $220.47M | PE Ratio (TTM) -7.19 | Dividend Yield N/A |
EPS (TTM) $-0.48 | Revenue (TTM) N/A | Return On Equity (TTM) 24.11% |
Profit Margin N/A | Debt to Equity -0.06 | Quarterly Earnings Growth YoY 27.06% |
Galectin Therapeutics Inc. Quarterly Profit & Loss
All figures in USD
Galectin Therapeutics Inc. Annual Profit & Loss
All figures in USD
About Galectin Therapeutics Inc.
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. Galectin Therapeutics Inc. has a collaborative joint venture co-owned by SBH Sciences, Inc. with Galectin Sciences, LLC for the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Galectin Therapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $3.05 | $3.46 | +16.69% |
Jul 2026 | $4.61 | $2.96 | -35.96% |
Jun 2026 | $2.52 | $4.63 | +83.73% |
May 2026 | $2.25 | $2.52 | +11.50% |
Apr 2026 | $2.84 | $2.26 | -19.00% |
Mar 2026 | $3.06 | $2.79 | -6.22% |
Feb 2026 | $2.90 | $2.98 | +5.12% |
Jan 2026 | $4.22 | $2.83 | -31.81% |
Dec 2025 | $5.71 | $4.15 | -27.19% |
Nov 2025 | $5.71 | $5.70 | -1.72% |
Oct 2025 | $4.32 | $5.80 | +35.83% |
Sep 2025 | $4.29 | $4.27 | +0.47% |
GALT Share Price FAQs
What is Galectin Therapeutics Inc. share price today?
What is the 52 week high and 52 week low of Galectin Therapeutics Inc. stock?
What is GALT's market capitalisation today?
What is GALT's net income for the last quarter?
What is the 5 year returns of GALT?
What is the high & low stock price of GALT today?
Can I buy GALT shares in India?